Cancer news and cancer widget

November is National Pancreatic cancer Awareness Month. I hope each of you take the time to learn about this devastating cancer, in hopes to raise awareness. people aren't as knowledgeable...

Primary HCC is a major cancer related to HBV viral infection in Asian countries, including Japan. Recently, the primary liver cancers are successfully treated by surgical resection including liver transplantation and non-surgical locoregional therapy. Although infrequently, extrahepatic spread to the lungs occurs. So-called lung metastasis from liver cancer is a dilemma, because it is often believed that diseases are very advanced and too late for adequate treatment.

Two proteins interact in a previously unknown molecular mechanism that may have broad implications in future studies looking for the causes of defective organs in fetuses, metastatic cancers and other diseases, according to researchers at Cincinnati Children's hospital Medical Center. Reporting their work in Genes & Development, the researchers said the mechanism coordinates cell identity and behavior in the forming organs of embryos.

Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced initial results from multi-center Phase 1 clinical trials of its cancer vaccine candidate, CDX-1307, combined with GM-CSF, at the International Society for the Biologic Therapy of Cancer (iSBTc) annual meeting in San Diego. These data provide the basis for the ongoing assessment of CDX-1307 combined with more potent adjuvants with data expected in the first half of 2009.

TACE has been widely accepted as a choice of treatment for advanced HCC. CT perfusion is a non-invasive and reproducible technique for assessing perfusion changes due to TACE therapy for locally advanced HCC. However, there are few reports on the application of this technique in evaluating the efficacy of TACE based on quantitative analysis of perfusion parameters. A research article published on October 7, 2008 in the World Journal of Gastroenterology refers.

A study published in the journal Clinical cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers.

Brain tumour advocates throughout the world have achieved their target of walking the equivalent of three times the distance around the Earth at the Equator. The target was 120,000 kms and 28,618 walkers in over 100 separate walks in 15 different countries in North and South America, Europe and Asia, have so far reached a combined total of 123,024 kms with more results still to arrive. The Walk Around the World for Brain Tumours is now an annual event.

Pre-clinical studies presented at the 9th International Conference on Membrane Redox Systems in Wellington New Zealand this week demonstrate that Novogen's NV-128 (a novel mTOR inhibitor), when used in combination with the Marshall Edwards, Inc.'s Phase III anti-ovarian cancer drug, phenoxodiol, produces potent synergistic anti-cancer activity against non-small cell lung carcinoma cell lines (NSCLC).

UroToday.com - In the online edition of Psycho-Oncology, a group of American investigators reported on the link between personality and prostate cancer (CaP) decision-making and satisfaction. This intriguing paper evaluated the optimist's ability to engage more fully and effectively in coping with or meeting an important challenges and how optimism may also positively impact CaP decision-making outcomes.

UroToday.com - Prostate cancer radiation therapy series demonstrates an increased risk of bladder cancer and rectal cancer in men who received radiotherapy for prostate cancer. The authors estimated the risk of secondary bladder cancer and rectal cancer after prostate radiotherapy using a contemporary population based cohort.